Status: Baseline only
Prevent an increase in the proportion of domestically-acquired Campylobacter jejuni infections in humans that are resistant to macrolides
Baseline: 2.5 percent of domestically-acquired Campylobacter jejuni infections in humans were resistant to macrolides in 2014-16
Target: 2.5 percent
Campylobacter jejuni is one of the major causes of foodborne illness in the United States, and antibiotic treatment is recommended for severe infections. Every year, many people get Campylobacter jejuni infections that are resistant to the macrolide class of antibiotics. Careful use of macrolide antibiotics and strategies that reduce antibiotic-resistant Campylobacter in animals raised for food are critical for preventing macrolide antibiotic-resistant Campylobacter jejuni infections in humans.
Workgroup: Food Safety Workgroup